openPR Logo
Press release

Adrenal crisis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes

10-06-2025 09:41 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Adrenal crisis Market to Evolve Rapidly Over the Next Decade

DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Adrenal crisis Market Report:
• The Adrenal crisis market size was valued approximately USD 11.5 Million in 2022 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• It is estimated that around 6-8% of patients diagnosed with adrenal insufficiency experience an adrenal crisis annually.
• According to the analysis, over 400 patients with Adrenal Insufficiency experience approximately 8 adrenal crises per 100 patient-years.
• The observed prevalence rates among the patient population are around 38% for primary adrenal insufficiency, 57% for secondary adrenal insufficiency, and 6% for congenital adrenal hyperplasia (CAH). Additionally, conventional hydrocortisone replacement therapy is expected to be more frequently used than prednisolone, with dexamethasone being the least commonly utilized.
• Key Adrenal crisis Companies: Pfizer Inc., Takeda Pharmaceutical, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma, Mallinckrodt Pharmaceutical, Mylan Pharmaceutical, AG eTon Pharmaceuticals, and others
• Key Adrenal crisis Therapies: SOLU-CORTEF, ATRS-1902, and others
• The Adrenal crisis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Adrenal crisis pipeline products will significantly revolutionize the Adrenal crisis market dynamics.

Adrenal crisis Overview
An adrenal crisis, also known as an acute adrenal crisis or adrenal insufficiency crisis, is a life-threatening medical emergency that occurs when the adrenal glands fail to produce an adequate amount of cortisol, a vital hormone responsible for regulating various bodily functions, particularly in times of stress. Adrenal crisis typically occurs in individuals with underlying adrenal insufficiency, such as those with Addison's disease or individuals who have undergone bilateral adrenalectomy.

Get a Free sample for the Adrenal crisis Market Report:
https://www.delveinsight.com/report-store/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Adrenal crisis Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Adrenal crisis Epidemiology Segmentation:
The Adrenal crisis market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalence of Adrenal crisis
• Prevalent Cases of Adrenal crisis by severity
• Gender-specific Prevalence of Adrenal crisis
• Diagnosed Cases of Episodic and Chronic Adrenal crisis

Download the report to understand which factors are driving Adrenal crisis epidemiology trends @ Adrenal crisis Epidemiology Forecast
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Adrenal crisis Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Adrenal crisis market or expected to get launched during the study period. The analysis covers Adrenal crisis market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Adrenal crisis Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Adrenal crisis Therapies and Key Companies
• SOLU-CORTEF: Pfizer Inc.
• ATRS-1902: Antares Pharma

Discover more about therapies set to grab major Adrenal crisis market share @ Adrenal crisis Treatment Market
https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Adrenal crisis Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Adrenal crisis Companies: Pfizer Inc., Takeda Pharmaceutical, Sandoz International GmbH, Pfizer Inc, Bristol-Myers Squibb, Merck KGaA, Antares Pharma, Mallinckrodt Pharmaceutical, Mylan Pharmaceutical, AG eTon Pharmaceuticals, and others
• Key Adrenal crisis Therapies: SOLU-CORTEF, ATRS-1902, and others
• Adrenal crisis Therapeutic Assessment: Adrenal crisis current marketed and Adrenal crisis emerging therapies
• Adrenal crisis Market Dynamics: Adrenal crisis market drivers and Adrenal crisis market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Adrenal crisis Unmet Needs, KOL's views, Analyst's views, Adrenal crisis Market Access and Reimbursement

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Adrenal crisis Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes here

News-ID: 4210471 • Views:

More Releases from DelveInsight Business Research

Panic Disorder Market Forecast 2032: Rising Global Prevalence and Emerging Therapies Reshape Treatment Landscape, estimates DelveInsight
Panic Disorder Market Forecast 2032: Rising Global Prevalence and Emerging Thera …
DelveInsight's "Panic Disorder Market Insights, Epidemiology, and Market Forecast-2032" report delivers a comprehensive evaluation of Panic Disorder, covering historical data, current trends, and future projections across major global markets, including the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. This latest healthcare market forecast offers an extensive assessment of the Panic Disorder landscape, providing detailed insights into revenue patterns, disease prevalence, and evolving treatment approaches. The
Catheter-related Bloodstream Infection (CRBSI) Pipeline Therapies Analysis 2025: Over 5 Companies Driving Innovation Across 5+ Therapies | DelveInsight
Catheter-related Bloodstream Infection (CRBSI) Pipeline Therapies Analysis 2025: …
DelveInsight's analysis highlights that the Catheter-related Bloodstream Infection (CRBSI) pipeline features over five leading companies actively advancing more than five therapeutic candidates aimed at improving CRBSI management. DelveInsight's "CRBSI Pipeline Insight 2025" report delivers an in-depth evaluation of ongoing clinical research activities and future growth opportunities within the CRBSI therapeutics landscape. The Surgical Site Infections Pipeline report offers comprehensive clinical and commercial insights into pipeline candidates ranging from preclinical and discovery stages
Hepatitis C Virus (HCV) Infection Pipeline Therapies 2025: Over 20 Companies Driving Innovation Across 20+ Therapies | DelveInsight
Hepatitis C Virus (HCV) Infection Pipeline Therapies 2025: Over 20 Companies Dri …
According to DelveInsight's evaluation, the global Hepatitis C Virus (HCV) Infection pipeline features more than 20 prominent pharmaceutical and biotechnology companies actively engaged in the development of over 20+ therapeutic candidates. The analysis spans clinical trial activity, therapeutic approaches, mechanisms of action, routes of administration, and recent developments shaping the Hepatitis C Virus Infection treatment landscape. The "Hepatitis C Virus Infection Pipeline Insight, 2025" report published by DelveInsight delivers an in-depth
Surgical Site Infections Pipeline Therapies Analysis 2025: Over 5 Companies Driving Innovation Across 5+ Therapies | DelveInsight
Surgical Site Infections Pipeline Therapies Analysis 2025: Over 5 Companies Driv …
Surgical Site Infections Pipeline Insight 2025: Over 5 Companies Driving Innovation Across 5+ Therapies | DelveInsight (Albany, United States) According to DelveInsight's analysis, the global Surgical Site Infections pipeline includes more than 5 leading companies actively engaged in the development of over 5 potential SSI therapies. The report provides detailed analysis across clinical trials, therapeutic approaches, mechanisms of action, routes of administration, and recent developmental activities. DelveInsight's "Surgical Site Infections Pipeline Insight,

All 5 Releases


More Releases for Adrenal

Adrenal Insufficiency Market to Reach USD 4.03 Billion by 2034
Pune, India - December 2025 - The global Adrenal Insufficiency Market, valued at USD 2.38 billion in 2024, is projected to reach USD 4.03 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of autoimmune disorders, enhanced diagnostic awareness, and advancements in glucocorticoid replacement therapies are fueling consistent market growth. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72005 Market Summary The Adrenal Insufficiency Market is
Adrenal crisis Market Insights Highlight Expanding Outlook Till 2034, DelveInsig …
DelveInsight's "Adrenal crisis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Adrenal crisis, historical and forecasted epidemiology as well as the Adrenal crisis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. To Know in detail about the Adrenal crisis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Adrenal crisis Market Forecast https://www.delveinsight.com/sample-request/adrenal-crisis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr Some of the
Rising Cigarette Smoking Boost The Adrenal Cancer: Key Factor Driving The Growth …
The Adrenal Cancer Diagnostics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Adrenal Cancer Diagnostics Market Size During the Forecast Period? Over the past few years, the market size for adrenal cancer diagnostics has been experiencing strong growth. It is projected to
Congenital Adrenal Hyperplasia Treatment Market Report and Forecast 2024-2032
The congenital adrenal hyperplasia treatment market size was valued at USD 422.9 million in 2023, driven by increasing government funding and assistance along with joint research. The market size is anticipated to grow at a CAGR of 8.10% during the forecast period of 2024-2032 to achieve a value of USD 852.42 million by 2032. Congenital Adrenal Hyperplasia Treatment: Introduction Congenital Adrenal Hyperplasia (CAH) treatment typically involves lifelong replacement of deficient hormones. For
Addison's Disease Testing: Diagnostic Approaches for Unveiling Adrenal Insuffici …
Addison Disease Testing Market 2023 Forecast: Unveiling Opportunities and Growth Addison Disease Testing Market research report helps to recognize the market challenges and opportunities. Global Addison Disease Testing Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including
Adrenal Insufficiency Market to Witness Growth by 2032, estimates DelveInsight
DelveInsight's "Adrenal Insufficiency Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Adrenal Insufficiency, historical and forecasted epidemiology as well as the Adrenal Insufficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Adrenal Insufficiency market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Adrenal Insufficiency market size